Hokkaido Cardiovascular Hospital

What Hokkaido Cardiovascular Hospital does

Hokkaido Cardiovascular Hospital (社会医療法人 北海道循環器病院) is a 95-bed cardiovascular specialty hospital operating in Sapporo, Hokkaido, Japan, founded in 1981 and reorganized as a Medical Corporation in 1988, with Social Medical Corporation status since 2011. The hospital delivers the full continuum of cardiovascular care — from prevention through acute intervention, surgery, and chronic heart failure management — across four core clinical specialties (cardiovascular surgery, cardiology, general medicine, respiratory medicine) plus specialized outpatient clinics for heart failure, arrhythmia, peripheral vascular disease, aortic aneurysm, sleep apnea, and smoking cessation.

Service capabilities span interventional catheterization (PCI with DCB/DES, TAVI, MitraClip, EVT, ablation), open cardiac and vascular surgery (CABG, valve surgery, MICS, aortic aneurysm repair, varicose vein laser treatment), cardiac rehabilitation (indoor and outdoor year-round programs), cardiovascular-focused outpatient dialysis, and preventive health screenings. Technology infrastructure includes a hybrid operating theater with Discovery IGS730 and Philips Allura Xper FD20 / Azurion7 angiography systems, GE Revolution CT with TrueFidelity and SnapShot Freeze 2.0, GE Vivid E95/E9 cardiovascular ultrasound, GE Infinia nuclear medicine gamma camera, and Canon Medical Systems' centralized pacemaker remote monitoring. The Advanced Medical Research Institute, established 2017, conducts R&D on the domestically-manufactured EVAHEART implantable ventricular assist device under Yamazaki Kenji.

The hospital generates approximately 95 beds, ~298 staff (Sept 2024), and annual procedural volumes of 336 PCI, 343 cardiac/thoracic surgical cases, 34 TAVI, 7 MitraClip, ~320 ablations, 57 EVT laser treatments, and 1,000+ cumulative varicose vein cases since 2012. Revenue flows through Japan's DPC (Diagnosis Procedure Combination) bundled payment system for acute inpatient care, fee-for-service for surgeries and procedures outside the DPC bundle, national health insurance reimbursements for outpatient services, preventive medicine center screenings, and patient amenity charges (special rooms ¥8,000/day, extended hospitalization ¥2,480/day). Patient acquisition is sales-led through regional clinic referrals, secondary emergency care designation, direct outpatient intake, and health checkup referrals, supported by a free shuttle bus network across four Sapporo districts and telemedicine services for remote Hokkaido patients.

Name

Hokkaido Cardiovascular Hospital

Legal name

社会医科大学 北海道循環器病院

Website

http://www.hokujun.or.jp

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

251–500 employees

Short description

Hokkaido Cardiovascular Hospital is a 95-bed cardiovascular specialty hospital in Sapporo, Japan, founded in 1981, delivering acute interventional cardiology, cardiac surgery, TAVI/MitraClip, ablation, cardiac rehabilitation, and heart failure management under Japan's national health insurance system for patients across Hokkaido.

Ownership category

akta.pro rank

Product category

Specialty Cardiovascular Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Outpatient Care Centers (6214)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Cardiac & Cardiothoracic Specialty Hospitals (HLAFAHAA)

akta.pro secondary industries

Cardiology Telemedicine Platforms (HLALAGAB), Cardiac & Pulmonary Clinical Home Health (e.g., CHF/COPD) (HSABACAI)

Keywords

• Cardiac catheterization treatment
• Heart failure management
• Cardiac rehabilitation services
• Preventive cardiovascular medicine
• Cardiovascular specialty hospital

Headquarters

HQ city

Sapporo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Acute Care Medical Services (急性期医療サービス): Revenue generated through Japan's DPC (Diagnosis Procedure Combination) diagnosis-group classification bundled payment system for acute inpatient care, covering hospitalization, procedures, medications, and diagnostics. The hospital's institutional coefficient is 1.4250 (base 1.0451 + function evaluation I 0.3003 + function evaluation II 0.0557 + emergency correction 0.0239). The hospital also bills on a fee-for-service basis for surgeries, anesthesia, rehabilitation, and certain procedures outside the DPC bundle.
2. Outpatient Medical Services (外来医疗服务): Outpatient consultation revenue under Japan's national health insurance scheme. Covers new patient consultations, return visits, specialized outpatient clinics, and diagnostic tests. Dialysis services are provided as outpatient care with cardiovascular-specialized monitoring.
3. Health Checkup and Screening Services (健康診断・人間ドッグ): Preventive medicine services through the 予防医学センター (Preventive Medicine Center) offering health examinations, human dock programs, and specific health checkups. Revenue from preventive health services.
4. Patient Amenity Charges (保険外併用療費用): Optional amenity charges including special room fees (¥8,000/day), 180+ day hospitalization surcharges (¥2,480/day), influenza vaccinations (¥3,870/dose), and selected rehabilitation charges. In addition, charges for services not covered under standard insurance such as medical certificates and certain consumables.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels4 records

Core offering

Hokkaido Cardiovascular Hospital is a specialty cardiovascular hospital providing comprehensive cardiovascular care including cardiac catheterization (PCI, TAVI, MitraClip, ablation), cardiac surgery, cardiac rehabilitation, heart failure management, and cardiovascular-focused outpatient dialysis. Operates as a Social Medical Corporation under Japan's universal health insurance system with 95 beds (including 6 ICU/CCU), serving patients in Sapporo and across Hokkaido through direct hospital services, free shuttle buses, telemedicine, and home visit care.

Product overview

Hokkaido Cardiovascular Hospital operates as a specialized cardiovascular medical institution offering a comprehensive range of circulatory disease diagnosis and treatment services. The hospital provides interventional catheter-based treatments (PCI, TAVI, MitraClip, ablation), cardiac surgery, cardiac rehabilitation, heart failure management, outpatient dialysis, remote pacemaker monitoring, preventive medicine, and clinical research. The service portfolio is organized around specialized centers including the Heart Failure Center, Cardiac Rehabilitation Center, Blood Purification Center, Heart Team for structural heart disease, and Advanced Medical Research Institute. Treatment capabilities include approximately 336 PCI procedures, 34 TAVI procedures, 7 MitraClip procedures, and 320 catheter ablation procedures annually. The hospital emphasizes a multidisciplinary team approach combining cardiology, cardiac surgery, nursing, pharmacy, rehabilitation, nutrition, and clinical engineering services.

Differentiator

Problem solved

Functional benefit

Brands

• 北海道循環器病院: Main hospital brand - cardiovascular specialty hospital in Sapporo
• 予防医学センター (Preventive Medicine Center)
• 心臓リハビリセンター (Cardiac Rehabilitation Center)
• 心不全センター (Heart Failure Center)
• 血液浄化センター (Blood Purification Center)
• 先進医療研究所 (Advanced Medical Research Institute)

Products and services

• Cardiac Catheterization Treatment

Quantifiable outcome

• TAVI complication rates: 0% all-cause mortality (most recent year), 0% emergency thoracotomy, pacemaker implantation 1 case (2025). TAVI outcomes comparable to or better than national averages published by Japanese Association for Catheter-Based Cardiac Valve Therapy.
• +7 more outcomes

Named customers1 record

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature11 records

Partnerships

Three partnerships are on record, tiered minor and core.

• KangoPlus Co., Ltd. (株式会社かんごぷらす)minorStrategic or Co-development Partner · 7 February 2025Collaboration on the 'まちの保健室×お出かけぷらす 地域包括ケア実証プロジェクト' (Community Health Room × Outing Plus Integrated Community Care Demonstration Project) in February 2025. Hospital's Administrative Director 宇野重起 delivered a presentation titled 'セカンドライフ ～人生100年時代の健康予防～' at UR Gokunren housing complex. Project aims to extend preventive health services into community settings beyond the hospital.
• Juntendo University School of Medicine / Juntendo University Hospital (順天堂大学医学部附属 順天堂医院)coreStrategic or Co-development Partner · 27 May 2024Collaborative research partnership in nuclear cardiology and cardiac imaging. Key publications include: (1) 'Lateral Planar Imaging of 99mTc-pyrophosphate Scintigraphy in Patients with Suspected Transthyretin Cardiac Amyloidosis' — co-authored by 斉藤利典 (Hokkaido Cardiovascular Hospital) and 相川忠夫 (Juntendo University Hospital), published in Annals of Nuclear Cardiology May 2024; (2) 'Impact of Region of Interest Size on Semi-Quantification of Myocardial 99mTc-pyrophosphate Uptake in Suspected Transthyretin Cardiac Amyloidosis' — co-authored paper published September 2025. Partnership enables cross-institutional cardiac amyloidosis imaging research and validation of new diagnostic methods.
• Hinode Dental Makomanai Clinic / Jin'yukai Group (仁友会 日之出歯科真駒内屎診所)minorStrategic or Co-development PartnerPartnership for dental visit services for inpatients and free dental consultations for outpatients at Hokkaido Cardiovascular Hospital. Dentists and dental hygienists from Hinode Dental conduct pre-surgical oral examinations for cardiac surgery patients and provide oral care to prevent aspiration pneumonia. Free dental consultations available Wednesdays 9:30-12:00 at hospital premises. The hospital coordinates dental care as part of comprehensive cardiovascular disease management, recognizing the link between oral health and cardiovascular/systemic health outcomes.

Scale indicators16 records

Recent moves16 records

Expansion highlights7 records

Direct peers

• Sakakibara Heart Institute: One of Japan's leading dedicated cardiovascular specialty hospitals, located in Fuchu, Tokyo. Operates as a Social Medical Corporation focused exclusively on cardiovascular care with high procedural volume and academic affiliations, directly comparable to Hokkaido Cardiovascular Hospital's specialty model and service mix (PCI, cardiac surgery, TAVI, ablation).
• Mitsui Memorial Hospital: Tokyo-based general hospital with a particularly strong cardiovascular center performing high volumes of PCI, cardiac surgery, TAVI, and arrhythmia ablation. Comparable as a Japanese cardiovascular specialty center with similar DPC-based economics and tertiary referral role.
• IMS Katsushika Heart Center: Tokyo-based dedicated cardiovascular specialty hospital within the IMS healthcare group. Operates as a high-volume cardiovascular intervention center with PCI, structural heart, and arrhythmia programs - structurally similar to Hokkaido Cardiovascular Hospital as a regional specialty referral destination.
• Edogawa Hospital: Tokyo-based community-oriented hospital with a strong cardiovascular focus including cardiac surgery, PCI, and structural heart interventions. Comparable mid-sized Japanese specialty hospital model with emphasis on community access and DPC-based economics.

Broad incumbents

• Juntendo University Hospital: Major Tokyo academic medical center with comprehensive cardiovascular services and an existing research partnership with Hokkaido Cardiovascular Hospital on cardiac amyloidosis imaging. Functions as a larger incumbent that both competes for complex referrals and collaborates on research.
• Tokyo Women's Medical University Hospital: Tokyo academic medical center historically leading EVAHEART VAD development under Dr. Yamazaki (now at Hokkaido Cardiovascular Hospital). Comparable as a cardiovascular research hub with strong academic ties; functions as a research partner and broader incumbent rather than a direct specialty competitor.
• National Cerebral and Cardiovascular Center: Japan's national specialty hospital for cardiovascular and cerebrovascular disease in Suita, Osaka. Functions as a research-driven incumbent with significantly larger scale, advanced VAD/transplant programs, and national-level training designation that anchors the specialty hospital category in Japan.

Regional players

• Sapporo Medical University Hospital: Primary academic medical center in Sapporo and the hospital's main regional referral partner and competitor. Provides comprehensive cardiovascular services including complex interventions; overlap is greatest in Hokkaido-based patient referrals and physician training.
• Hokkaido University Hospital: Hokkaido's flagship academic medical center in Sapporo, providing advanced cardiovascular care including transplantation and complex structural heart interventions. Competes for tertiary referrals in the same regional catchment as Hokkaido Cardiovascular Hospital.

Others

• Kangoplus Co., Ltd. Healthcare community-services partner collaborating with Hokkaido Cardiovascular Hospital on the 'Community Health Room x Outing Plus Integrated Community Care Demonstration Project'. Functions as an enabling ecosystem partner for extending preventive health services beyond the hospital.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCVouRORYhSIw7zrNNXjmpDQ
• Facebookfacebook.com/hokujun/?ref=embed_page

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hokkaido Cardiovascular Hospital